相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
Giselle L. Saulnier Sholler et al.
PLOS ONE (2015)
Novel Interaction of Ornithine Decarboxylase with Sepiapterin Reductase Regulates Neuroblastoma Cell Proliferation
Ingo Lange et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patients
Andrea Bandino et al.
CELLULAR ONCOLOGY (2014)
AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport
Katherine Samal et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
Susan G. Kreissman et al.
LANCET ONCOLOGY (2013)
New functional families (FunFams) in CATH to improve the mapping of conserved functional sites to 3D structures
Ian Sillitoe et al.
NUCLEIC ACIDS RESEARCH (2013)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
Analgesia by inhibiting tetrahydrobiopterin synthesis
Michael Costigan et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641
Douglas R. Strother et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis
Christopher Chidley et al.
NATURE CHEMICAL BIOLOGY (2011)
PubChem3D: a new resource for scientists
Evan E. Bolton et al.
JOURNAL OF CHEMINFORMATICS (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Neuroblastoma: Biology, Prognosis, and Treatment
Julie R. Park et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma.
David L. Baker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
Robert J. Rounbehler et al.
CANCER RESEARCH (2009)
Poor Survival for Infants With MYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
Adela Canete et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma
Dana-Lynn T. Koomoa et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Ornithine Decarboxylase Inhibition by α-Difluoromethylornithine Activates Opposing Signaling Pathways via Phosphorylation of Both Akt/Protein Kinase B and p27Kip1 in Neuroblastoma
Dana-Lynn T. Koomoa et al.
CANCER RESEARCH (2008)
ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
Michael D. Hogarty et al.
CANCER RESEARCH (2008)
The MSX1 homeobox transcription factor is a downstream target of PHOM and activates the Delta-Notch pathway in neuroblastoma
Ingrid Revet et al.
EXPERIMENTAL CELL RESEARCH (2008)
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
Robert A. Casero et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Polyamines and neoplastic growth
A. E. Pegg et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells
CJ Wallick et al.
ONCOGENE (2005)
Polyamines and cancer: Old molecules, new understanding
EW Gerner et al.
NATURE REVIEWS CANCER (2004)
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma
BH Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Neuroblastoma: biology and molecular and chromosomal pathology
M Schwab et al.
LANCET ONCOLOGY (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
The Protein Data Bank
HM Berman et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
分享论文
